Annexon, Inc. (ANNX)
NASDAQ: ANNX · IEX Real-Time Price · USD
4.330
-0.030 (-0.69%)
At close: May 17, 2024, 4:00 PM
4.390
+0.060 (1.39%)
After-hours: May 17, 2024, 6:47 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $396.47 million as of May 17, 2024. Its market cap has increased by 35.78% in one year.
Market Cap
396.47M
Enterprise Value
161.27M
1-Year Change
35.78%
Ranking
Category
Stock Price
$4.33
Market Cap Chart
Since July 24, 2020, Annexon's market cap has decreased from $599.60M to $396.47M, a decrease of -33.88%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 400.10M | -0.69% |
| May 16, 2024 | 402.90M | -3.13% |
| May 15, 2024 | 415.90M | -6.62% |
| May 14, 2024 | 445.40M | -1.04% |
| May 13, 2024 | 450.10M | 5.26% |
| May 10, 2024 | 427.60M | -6.86% |
| May 9, 2024 | 459.10M | 4.72% |
| May 8, 2024 | 438.40M | 2.96% |
| May 7, 2024 | 425.80M | -1.66% |
| May 6, 2024 | 433.00M | -1.43% |
| May 3, 2024 | 439.30M | 4.72% |
| May 2, 2024 | 419.50M | -1.89% |
| May 1, 2024 | 427.60M | 4.39% |
| Apr 30, 2024 | 409.60M | -3.19% |
| Apr 29, 2024 | 423.10M | - |
| Apr 26, 2024 | 423.10M | 2.40% |
| Apr 25, 2024 | 413.20M | 3.15% |
| Apr 24, 2024 | 400.60M | 0.23% |
| Apr 23, 2024 | 399.70M | -2.32% |
| Apr 22, 2024 | 409.20M | -0.32% |
| Apr 19, 2024 | 410.50M | 2.70% |
| Apr 18, 2024 | 399.70M | -3.17% |
| Apr 17, 2024 | 412.80M | -10.36% |
| Apr 16, 2024 | 460.50M | -10.88% |
| Apr 15, 2024 | 516.70M | -4.03% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enhabit | 413.38M |
| Health Catalyst | 410.29M |
| Bioventus | 408.50M |
| ADC Therapeutics | 401.74M |
| Esperion Therapeutics | 399.63M |
| Replimune Group | 394.11M |
| C4 Therapeutics | 389.44M |
| ModivCare | 389.09M |